Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ACHC Stock Forecast 2026-2027
$32.26
Current Price
$2.91B
Market Cap
Buy 8
Hold 5
Sell 1
Wall St Analyst Ratings
Distance to ACHC Price Targets
+24.0%
To High Target of $40.00
-3.9%
To Median Target of $31.00
-59.7%
To Low Target of $13.00
ACHC Price Momentum
+2.8%
1 Week Change
+29.1%
1 Month Change
+42.3%
1 Year Change
+127.4%
Year-to-Date Change
-3.7%
From 52W High of $33.50
+182.2%
From 52W Low of $11.43
📊 TOP ANALYST CALLS
Did ACHC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Acadia Healthcare is one of their latest high-conviction picks.
Latest ACHC Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, ACHC has a bullish consensus with a median price target of $31.00 (ranging from $13.00 to $40.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $32.26, the median forecast implies a -3.9% downside. This outlook is supported by 8 Buy, 5 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Matthew Gillmor at Keybanc, projecting a 24.0% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ACHC Analyst Ratings
8
Buy
5
Hold
1
Sell
ACHC Price Target Range
Low
$13.00
Average
$31.00
High
$40.00
Current: $32.26
Latest ACHC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ACHC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jul 14, 2026 | Keybanc | Matthew Gillmor | Overweight | Maintains | $40.00 |
| Jul 9, 2026 | UBS | A.J. Rice | Buy | Maintains | $39.00 |
| Jun 3, 2026 | Jefferies | Buy | Upgrade | $N/A | |
| May 4, 2026 | RBC Capital | Outperform | Maintains | $N/A | |
| May 4, 2026 | Guggenheim | Buy | Maintains | $N/A | |
| May 1, 2026 | Cantor Fitzgerald | Neutral | Maintains | $N/A | |
| May 1, 2026 | Barclays | Equal-Weight | Maintains | $N/A | |
| Apr 28, 2026 | TD Cowen | Buy | Maintains | $N/A | |
| Apr 17, 2026 | UBS | Buy | Maintains | $N/A | |
| Mar 3, 2026 | Barclays | Equal-Weight | Maintains | $N/A | |
| Feb 26, 2026 | Leerink Partners | Market Perform | Maintains | $N/A | |
| Feb 26, 2026 | UBS | Buy | Maintains | $N/A | |
| Feb 26, 2026 | TD Cowen | Buy | Maintains | $N/A | |
| Feb 26, 2026 | RBC Capital | Outperform | Maintains | $N/A | |
| Feb 23, 2026 | Guggenheim | Buy | Maintains | $N/A | |
| Jan 22, 2026 | Jefferies | Hold | Downgrade | $N/A | |
| Jan 16, 2026 | TD Cowen | Buy | Maintains | $N/A | |
| Jan 14, 2026 | RBC Capital | Outperform | Maintains | $N/A | |
| Dec 18, 2025 | Mizuho | Neutral | Maintains | $N/A | |
| Dec 4, 2025 | Barclays | Equal-Weight | Maintains | $N/A |
Acadia Healthcare Co Inc (ACHC) Competitors
The following stocks are similar to Acadia Healthcare based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ACHC
Acadia Healthcare
mkt cap
2.88B
Acadia Healthcare Co Inc (ACHC) Financial Data
Acadia Healthcare Co Inc has a market capitalization of $2.91B with a P/E ratio of 20.6x. The company generates $3.37B in trailing twelve-month revenue with a -32.8% profit margin.
Revenue growth is +7.6% quarter-over-quarter, while maintaining an operating margin of +10.1% and return on equity of -41.1%.
Valuation Metrics
Market Cap
$2.91B
Enterprise Value
$5.55B
P/E Ratio
20.6x
PEG Ratio
-0.5x
Price/Sales
0.8x
Growth & Margins
Revenue Growth (YoY)
+7.6%
Gross Margin
+96.4%
Operating Margin
+10.1%
Net Margin
-32.8%
EPS Growth
-51.0%
Financial Health
Cash/Price Ratio
+5.3%
Current Ratio
1.7x
Debt/Equity
124.2x
ROE
-41.1%
ROA
+4.2%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Acadia Healthcare Co Inc (ACHC) Business Model
About Acadia Healthcare Co Inc
What They Do
Provider of behavioral healthcare services.
Business Model
The company operates a network of treatment facilities focusing on mental health and substance use disorders. It generates revenue primarily through inpatient psychiatric services, outpatient behavioral health programs, and adolescent residential treatment.
Additional Information
Acadia Healthcare serves a diverse clientele, including children, adolescents, adults, and seniors, with various levels of care from acute crisis stabilization to long-term therapeutic programs. It is recognized as one of the larger dedicated behavioral health systems in the U.S., contributing to increased access to essential behavioral health services.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
25,000
CEO
Ms. Debra K. Osteen
Country
United States
IPO Year
1994
Website
www.acadiahealthcare.comAcadia Healthcare Co Inc (ACHC) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Are Options Traders Betting on a Big Move in Acadia Healthcare Stock?
Investors need to pay close attention to (Ticker) stock based on the movements in the options market lately.
Jul 07, 2026
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Acadia Healthcare (NASDAQ: ACHC) will release its Q2 2026 results on July 28, 2026, after market close, followed by a conference call on July 29 at 9:00 a.m. ET.
Why It Matters
Acadia Healthcare's upcoming earnings release and conference call may influence stock performance and investor sentiment, providing insights into its financial health and strategic direction.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
The Zacks Medical-Hospital industry is evolving with increased demand and improved earnings outlook as care shifts from inpatient settings. Notable companies include THC, UHS, ACHC, and CYH.
Why It Matters
The shift to outpatient care and improved earnings outlook in the medical-hospital sector signals potential growth for companies like THC, UHS, ACHC, and CYH, influencing investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
ACHC is transitioning from expansion to focusing on returns, increasing EBITDA guidance due to improved performance of mature facilities and rising demand.
Why It Matters
ACHC's shift to prioritizing returns and raised EBITDA guidance indicates improved profitability, signaling potential for higher shareholder value and increased investor confidence.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Short sellers are increasing their positions in 10 stocks, with short interest levels between 37% and 87%, indicating heightened bearish sentiment.
Why It Matters
High short interest indicates investor pessimism, suggesting potential volatility. A significant rise in short selling may signal upcoming price declines or market corrections.
Source: Benzinga
Market Sentiment:
Negative
Quick Summary
Acadia Healthcare (ACHC) reported earnings 30 days ago; investors should monitor upcoming developments for potential stock movements.
Why It Matters
Earnings reports influence stock prices and investor sentiment. Acadia Healthcare's recent performance may signal growth potential or risks, affecting future stock valuation and investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
ACHC shares have risen 82% year-to-date, driven by increased bed capacity, improved cash flow, and growing demand for behavioral health services.
Why It Matters
ACHC's 82% YTD share surge reflects strong growth prospects. Increased bed capacity and cash flow alongside rising demand in behavioral health signal potential for continued profitability and investor interest.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About ACHC Stock
What is Acadia Healthcare Co Inc's (ACHC) stock forecast for 2027?
Based on our analysis of 3 Wall Street analysts, Acadia Healthcare Co Inc (ACHC) has a median price target of $31.00. The highest price target is $40.00 and the lowest is $13.00.
Is ACHC stock a good investment in 2027?
According to current analyst ratings, ACHC has 8 Buy ratings, 5 Hold ratings, and 1 Sell ratings. The stock is currently trading at $32.26. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ACHC stock?
Wall Street analysts predict ACHC stock could reach $31.00 in the next 12 months. This represents a -3.9% decrease from the current price of $32.26. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Acadia Healthcare Co Inc's business model?
The company operates a network of treatment facilities focusing on mental health and substance use disorders. It generates revenue primarily through inpatient psychiatric services, outpatient behavioral health programs, and adolescent residential treatment.
What is the highest forecasted price for ACHC Acadia Healthcare Co Inc?
The highest price target for ACHC is $40.00 from Matthew Gillmor at Keybanc, which represents a 24.0% increase from the current price of $32.26.
What is the lowest forecasted price for ACHC Acadia Healthcare Co Inc?
The lowest price target for ACHC is $13.00 from at , which represents a -59.7% decrease from the current price of $32.26.
What is the overall ACHC consensus from analysts for Acadia Healthcare Co Inc?
The overall analyst consensus for ACHC is bullish. Out of 3 Wall Street analysts, 8 rate it as Buy, 5 as Hold, and 1 as Sell, with a median price target of $31.00.
How accurate are ACHC stock price projections?
Stock price projections, including those for Acadia Healthcare Co Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 16, 2026 2:01 AM UTC